Open AccessA Case Report on Neonatal Giant Hepatic Hemangioma
Author(s) -
Nadia Mebrouk,
Amina Barkat
Publication year - 2021
Publication title -
asian journal of pediatric research
Language(s) - English
Resource type - Journals
ISSN - 2582-2950
DOI - 10.9734/ajpr/2021/v5i330175
Subject(s) - propranolol , medicine , hemangioma , cortisone , infantile hemangioma , vitamin d and neurology , surgery
Hepatic hemangioma is the third most common pediatric tumor, and it is rare in the neonatal period. Because of its rarity, a treatment strategy for this disease is still being established.
Patient and Methods: A neonate girl was referred to our unit for hepatomegaly. She had a very high Alpha-fetoproteins, and the abdominal scan showed a large mass with no vascular invasion nor deep lymphadenopathy. She was diagnosed with hepatic hemangioma and treated successfully with propranolol and cortisone. After 17 months of treatment, the patient’s hepatomegaly was reduced by 97.3%.
Results: Report on successful treatment, with no side effects, for hepatic hemangioma with propranolol and cortisone associated with calcium, potassium, and vitamin D.
Conclusion: The patient’s large focal hepatic hemangioma was treated successfully with propranolol. The treatment included cortisone for one month, associated with calcium, potassium, and vitamin D.